Global Narcolepsy Drugs Market Report 2024-2032: Therapeutic Types, Disease Types, End Users, Countries, and Company Analysis Featuring Jazz Pharmaceuticals, Ligand Pharmaceuticals, Novartis, and More
July 30, 2024 08:01 ET
|
Research and Markets
Dublin, July 30, 2024 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Drugs Market Report by Therapeutic Type Disease Type End Users Countries and Company Analysis, 2024-2032" report has been added to ...
Autistic Disorder Pipeline Insight Report 2024, Featuring Key Products Tasimelteon, Cariprazine, L1-79, JZP541, AB-2004, RO6953958 and SB-121
April 22, 2024 11:10 ET
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Autistic Disorder - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive...
Narcolepsy Drugs Industry Outlook to 2030: Emphasizing Growth in the Sodium Oxybate and Central Nervous System Stimulants Segments
January 24, 2024 14:35 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Drugs Market (By Therapeutic Type, Disease Type, End User, Regional Analysis), Pipeline Analysis, Key Company Profiles and Recent...
Sodium Oxybate Takes Center Stage in Narcolepsy Treatment: Key Player in $5.95 Billion Narcolepsy Drugs Industry by 2030
November 07, 2023 06:48 ET
|
Research and Markets
Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The "Narcolepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has...
Global Acute Migraine Drugs Market Report 2023: A $14.06 Billion Market by 2028 Featuring Key Players - Eli Lilly and Co, GSK, Bayer, J&J, Teva, AbbVie, Novartis, Merck, Pfizer, & Boehringer Ingelheim
March 10, 2023 05:53 ET
|
Research and Markets
Dublin, March 10, 2023 (GLOBE NEWSWIRE) -- The "Global Acute Migraine Drugs Market - Analysis By Drug Type (Ergot Alkaloids, Analgesics, Triptans, Others), Route of Administration, Availability, By...
The Worldwide Narcolepsy Therapeutics Industry is Projected to Reach $3.6 Billion by 2030 at a CAGR of 7.3%
February 16, 2023 11:33 ET
|
Research and Markets
Dublin, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The "Narcolepsy Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Narcolepsy...
Autism Spectrum Disorder Treatment Global Market Report 2022: Sector to Grow by 6.47% Annually Through 2033
December 29, 2022 07:08 ET
|
Research and Markets
Dublin, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The "Autism Spectrum Disorder Treatment Market by Treatment, Application, Distribution Channel, and by Region - Global Forecast to 2022-2033" report has...
Global Narcolepsy Drugs Market Report 2022 - Sodium Oxybate Dominates, Owing to Its Dual-Pronged Approach in Treating Daytime Extreme Sleepless and Cataplexy
February 28, 2022 05:28 ET
|
Research and Markets
Dublin, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Drugs Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been...